Zynex, Inc. Q3 2025 Earnings Recap

ZYXI Q3 2025 November 18, 2025

Get alerts when ZYXI reports next quarter

Zynex, Inc. reported a challenging third quarter for 2025 marked by significant management changes and strategic pivots aimed at addressing compliance issues and improving financial stability.

Earnings Per Share Miss

$-0.41 vs $-0.19 est.

-115.8% surprise

Revenue Miss

13360000 vs 25530000 est.

-47.7% surprise

Market Reaction

1-Day -25.68%

5-Day +9.34%

30-Day +30.68%

See ZYXI alongside your other holdings

Add to your portfolio — free

Key Takeaways

Newly appointed management is focused on compliance, governance, and strategic marketing to turn the company around.
A proactive resupply order fulfillment policy has led to increased patient engagement and improved customer experience.
The company faces liquidity challenges with $60 million in convertible senior notes maturing in May 2026, necessitating urgent capital raising efforts.
Initial signs of stabilization in customer order volumes have been observed despite a reduced sales force, supported by revamped commission plans and focused sales strategies.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ZYXI on AllInvestView.